Guardant Health (GH) Cost of Revenue (2017 - 2026)

Guardant Health has disclosed Cost of Revenue across 10 years of filings, most recently posting $104.9 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $104.9 million, up 40.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $311.2 million (up 23.87% YoY), and the FY2025 annual result was $349.0 million, up 20.43% from the prior year.
• Cost of Revenue came in at $104.9 million for Q1 2026 at Guardant Health, up from -$2.3 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $127.4 million in Q3 2025 to a low of -$132.7 million in Q4 2023.
• The 5-year median for Cost of Revenue is $73.6 million (2022), against an average of $59.5 million.
• Across the five-year window, Cost of Revenue slumped 262.98% in 2023 and soared 122.33% in 2024, its largest moves.
• Guardant Health's Cost of Revenue stood at $81.4 million in 2022, then plunged by 262.98% to -$132.7 million in 2023, then surged by 122.33% to $29.6 million in 2024, then plunged by 107.67% to -$2.3 million in 2025, then surged by 4717.91% to $104.9 million in 2026.
• The last three Cost of Revenue figures came in at $104.9 million (Q1 2026), -$2.3 million (Q4 2025), and $127.4 million (Q3 2025), per Business Quant data.